

One of the medications, atomoxetine, approved by the U.S. Food and Drug Administration (FDA) in 2002 for attention-deficit/hyperactivity disorder, increases levels of the excitatory neurotransmitter norepinephrine by blocking its reuptake (…). In sleep apnea patients, it’s known that the decline of norepinephrine during sleep contributes to a loss of tone among upper airway muscles, particularly the genioglossus. The other compound, called aroxybutynin, is a chemically tweaked form of a drug used to treat overactive bladder. It blocks certain receptors for acetylcholine, preventing this neurotransmitter from inhibiting the nerve that enervates genioglossus—effectively toning up the muscle during sleep.





Fuck every Axel Springer Publication, which includes Politico